• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, July 31, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

UTHealth researcher reveals results of study on emergency breathing tubes

Bioengineer by Bioengineer
May 16, 2018
in Biology
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: PHOTO CREDIT Dwight Andrews, UTHealth

In a landmark study, researchers found that patients treated with paramedic oxygen delivery using a newer, more flexible laryngeal breathing tube may have a greater survival rate after sudden cardiac arrest than the traditional intubation breathing tube.

Funded by the National Heart, Lung, and Blood Institute (NHLBI), the study is the largest of its kind to test oxygen delivery methods used by firefighters, emergency medical technicians and paramedics. The study was presented at the 2018 Society for Academic Emergency Medicine meeting in Indianapolis, Indiana by lead author Henry E. Wang, M.D., M.S., professor and vice chair for research in the Department of Emergency Medicine at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth).

"For over three decades, emergency medical services personnel in the U.S. have performed intubation to deliver oxygen into the lungs of cardiac arrest victims. While identical to techniques used by doctors in the hospital, intubation in the prehospital setting is very difficult and fraught with errors," Wang said. "Our trial showed that cardiac arrest patients treated using the newer and easier laryngeal tube device may have a higher survival rate."

Sudden cardiac arrest, or loss of mechanical activity of the heart, is usually caused by a heart attack. More than 400,000 individuals are treated for out-of-hospital cardiac arrest each year, with the vast majority occurring at home, according to the American Heart Association. Studies show that only about 10 percent of people who suffer cardiac arrest outside the hospital survive. Delivery of oxygen to the lungs is a critical part of reviving a patient from cardiac arrest.

The multicenter research study – Pragmatic Airway Resuscitation Trial – compared survival rates among 3,000 adults with cardiac arrest treated by paramedic crews from 27 emergency medical services (EMS) agencies from December 2015 to November 2016. Approximately half received the newer laryngeal tube (LT) airway, while the other half received traditional endotracheal intubation. The study (NHLBI grant UH2/UH3-HL125163) was conducted by the Resuscitation Outcomes Consortium research network and included the Birmingham, Dallas-Fort Worth, Milwaukee, Pittsburgh and Portland communities.

Overall, survival was higher in the LT than the standard intubation group. In the LT group, 18.3 percent survived three days in the hospital, while in the intubation group, 15.4 percent survived three days. A total of 10.8 percent in the LT group survived to reach hospital survival, while 8.1 percent in the intubation group reached hospital survival. The proportion of patients surviving with good brain function was also higher for LT than standard intubation.

"This is the first randomized trial to show that a paramedic airway intervention can improve cardiac arrest survival," Wang said. "Based upon these results, use of the newer LT devices could result in more than 10,000 additional lives saved each year."

While additional research is needed to support the study's findings, the researchers believe that the benefits of the newer LT airway are due to its easier technique, leading to better blood flow and oxygen delivery. They are continuing to analyze the data to gain additional insight into the study results.

###

Media Contact

Rob Cahill
[email protected]
713-500-3030

http://www.uthouston.edu

Share12Tweet7Share2ShareShareShare1

Related Posts

Cemiplimab and fianlimab with neoadjuvant chemotherapy in early-stage high-risk -negative breast cancer

Cemiplimab and fianlimab with neoadjuvant chemotherapy in early-stage high-risk -negative breast cancer

July 30, 2026
Combined phage therapy and faecal microbiota transplantation to treat recurrent urinary tract infection: a case series

Combined phage therapy and faecal microbiota transplantation to treat recurrent urinary tract infection: a case series

July 30, 2026

Essential genetic mutations impair DNA damage repair and modulate tumor immune microenvironment in ccRCC

July 30, 2026

Microbiota-derived 10-hydroxystearic acid activates PPARα to restore gut epithelial barrier integrity and enhance anti-retroviral therapy

July 30, 2026
Please login to join discussion

POPULAR NEWS

  • Cemiplimab and fianlimab with neoadjuvant chemotherapy in early-stage high-risk -negative breast cancer

    29 shares
    Share 12 Tweet 7
  • Combined phage therapy and faecal microbiota transplantation to treat recurrent urinary tract infection: a case series

    29 shares
    Share 12 Tweet 7
  • Representations of the intrinsic value of information in mouse orbitofrontal cortex

    29 shares
    Share 12 Tweet 7
  • Pilot study to validate endothelium collection from pulmonary artery balloon catheter in children

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Cemiplimab and fianlimab with neoadjuvant chemotherapy in early-stage high-risk -negative breast cancer

Combined phage therapy and faecal microbiota transplantation to treat recurrent urinary tract infection: a case series

Representations of the intrinsic value of information in mouse orbitofrontal cortex

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.